Research Post

Predicting the long-term outcomes of biologics in psoriasis patients using machine learning


Real-world data demonstrate that ∼50% of psoriasis patients treated with a biologic agent will discontinue the drug because of a loss in efficacy. History of previous therapy with another biologic, female sex, and obesity were identified as predictors of drug discontinuations, but their individual predictive value is low.

Latest Research Papers

Connect with the community

Get involved in Alberta's growing AI ecosystem! Speaker, sponsorship, and letter of support requests welcome.

Explore training and advanced education

Curious about study options under one of our researchers? Want more information on training opportunities?

Harness the potential of artificial intelligence

Let us know about your goals and challenges for AI adoption in your business. Our Investments & Partnerships team will be in touch shortly!